Mdl-74156

Mdl-74156

SCHEMBL8339181

O=C(OC1CC2CC3C[C@@H](C1)N2C[C@H]3O)c1c[nH]c2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 1.00
HTR3A P46098 8/20 0.66
SLC6A4 P31645 2/20 0.66
HTR3E A5X5Y0 7/20 0.65
HTR3B O95264 7/20 0.65
HTR3D Q70Z44 7/20 0.65
HTR3C Q8WXA8 7/20 0.65
CHRNB2 P17787 3/20 0.65
CHRNA7 P36544 3/20 0.65
CHRNA4 P43681 3/20 0.65
CHRNA1 P02708 2/20 0.65
CHRNG P07510 2/20 0.65
CYP3A4 P08684 2/20 0.65
CYP2D6 P10635 2/20 0.65
CHRNB1 P11230 2/20 0.65
CHRNA3 P32297 2/20 0.65
CHRND Q07001 2/20 0.65
MAPT P10636 2/20 0.65
LMNA P02545 2/20 0.65
SMN1; SMN2 Q16637 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mdl-74156 SCHEMBL7281981 1.00 KCNH2 (1.00) KCNH2HTR3ASLC6A4HTR3EHTR3B
Mdl-74156 SCHEMBL29386901 1.00 KCNH2 (1.00) KCNH2HTR3ASLC6A4HTR3EHTR3B
Mdl-74156 SCHEMBL10512437 0.82 HTR3A (0.68) KCNH2HTR3ASLC6A4HTR3EHTR3B
SCHEMBL7289186 0.81 HTR3A (0.71) KCNH2HTR3ASLC6A4HTR3EHTR3B
SCHEMBL8323170 0.81 KCNH2 (0.68) KCNH2HTR3ASLC6A4HTR3EHTR3B
SCHEMBL8323177 0.81 KCNH2 (0.68) KCNH2HTR3ASLC6A4HTR3EHTR3B
Dolasetron SCHEMBL24914047 0.80 HTR3A (1.00) KCNH2HTR3ASLC6A4HTR3EHTR3B
Dolasetron SCHEMBL1819896 0.80 HTR3A (1.00) KCNH2HTR3ASLC6A4HTR3EHTR3B
Dolasetron SCHEMBL20769824 0.80 HTR3A (1.00) KCNH2HTR3ASLC6A4HTR3EHTR3B
Dolasetron SCHEMBL1819898 0.80 HTR3A (1.00) KCNH2HTR3ASLC6A4HTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5910501-A Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolozin-3(4H)-one and related compounds for treating cognitive disorders MERRELL PHARMACEUTICALS INC. (US) 1999-06-08 US claimed
EP-0494002-A2 Use of certain esters of hexahydro-8-hydroxy-2, 6-methano-2H-quinolizin-3(4H)-one and related compounds for the preparation of medicaments for treating cognitive disorders MERRELL DOW PHARMACEUTICALS INC. (US) 1992-07-08 EP claimed
US-5910501-A Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolozin-3(4H)-one and related compounds for treating cognitive disorders MERRELL PHARMACEUTICALS INC. (US) 1999-06-08 US disclosed
EP-0494002-A2 Use of certain esters of hexahydro-8-hydroxy-2, 6-methano-2H-quinolizin-3(4H)-one and related compounds for the preparation of medicaments for treating cognitive disorders MERRELL DOW PHARMACEUTICALS INC. (US) 1992-07-08 EP disclosed